BP’s Vertex Pharmaceuticals VRTX Stock Holding History

BP’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,858	Closed	-$1.18M	–	512
2021 Q2	$1.18M	Sell	5,858 -2,557	-30%	-$535K	0.05%	205
2021 Q1	$1.81M	Sell	8,415 -1,918	-19%	-$421K	0.06%	181
2020 Q4	$2.44M	Sell	10,333 -74,067	-88%	-$17M	0.07%	164
2020 Q3	$22.9M	Buy	84,400 +59,100	+234%	+$16.3M	0.56%	42
2020 Q2	$7.34M	Sell	25,300 -300	-1%	-$81.3K	0.27%	77
2020 Q1	$6.09M	Hold	25,600	–	–	0.26%	86
2019 Q4	$5.6M	Hold	25,600	–	–	0.19%	126
2019 Q3	$4.34M	Hold	25,600	–	–	0.16%	157
2019 Q2	$4.69M	Sell	25,600 -1,400	-5%	-$245K	0.17%	143
2019 Q1	$4.96M	Hold	27,000	–	–	0.19%	138
2018 Q4	$4.47M	Sell	27,000 -5,000	-16%	-$866K	0.19%	135
2018 Q3	$6.17M	Buy	32,000 +2,000	+7%	+$356K	0.19%	130
2018 Q2	$5.1M	Buy	30,000 +1,000	+3%	+$155K	0.16%	152
2018 Q1	$4.73M	Hold	29,000	–	–	0.17%	156
2017 Q4	$4.35M	Sell	29,000 -2,000	-6%	-$296K	0.15%	166
2017 Q3	$4.71M	Hold	31,000	–	–	0.17%	163
2017 Q2	$4M	Hold	31,000	–	–	0.15%	189
2017 Q1	$3.39M	Hold	31,000	–	–	0.13%	202
2016 Q4	$2.29M	Hold	31,000	–	–	0.09%	279
2016 Q3	$2.7M	Buy	31,000 +16,000	+107%	+$1.51M	0.1%	233
2016 Q2	$1.29M	Hold	15,000	–	–	0.05%	319
2016 Q1	$1.19M	Sell	15,000 -5,000	-25%	-$452K	0.05%	298
2015 Q4	$2.52M	Sell	20,000 -8,000	-29%	-$966K	0.1%	231
2015 Q3	$2.91M	Buy	28,000 +18,000	+180%	+$2.31M	0.13%	199
2015 Q2	$1.24M	Buy	+10,000	New	+$1.26M	0.05%	268

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BP's VRTX Position: Q3 2021 in Review

BP sold out of Vertex Pharmaceuticals (VRTX) in Q3 2021, closing a stake of 5,858 shares — an estimated $1.18M sold.

BP first reported a position in VRTX in Q2 2015 and held it in 25 quarters. The position peaked at $22.9M in Q3 2020. 935 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

BP reported no remaining Vertex Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
BP sold 5,858 Vertex Pharmaceuticals shares in Q3 2021, an estimated $1.18M.
BP first reported a position in Vertex Pharmaceuticals in Q2 2015 and held it in 25 quarters.
BP's Vertex Pharmaceuticals position peaked at $22.9M in Q3 2020.
935 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.